Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Globus Medical Company Profile (NASDAQ:GMED)

Consensus Ratings for Globus Medical (NASDAQ:GMED) (?)
Ratings Breakdown: 1 Hold Rating(s), 7 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.24 (16.28% upside)

Analysts' Ratings History for Globus Medical (NASDAQ:GMED)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/10/2014Brean CapitalInitiated CoverageBuy$28.00ViewTweet This Rating  Share This Rating on StockTwits
11/3/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
10/31/2014Canaccord GenuityReiterated RatingBuy$24.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2014ZacksUpgradeUnderperform -> Neutral$21.20ViewTweet This Rating  Share This Rating on StockTwits
10/1/2014ZacksDowngradeNeutral -> Underperform$18.70ViewTweet This Rating  Share This Rating on StockTwits
9/11/2014Piper JaffrayBoost Price TargetTop Pick$28.00ViewTweet This Rating  Share This Rating on StockTwits
9/11/2014JMP SecuritiesInitiated CoverageOutperform$25.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014GabelliInitiated CoverageBuy$30.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014OppenheimerReiterated RatingOutperform$28.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014WallachBeth CapitalUpgradeHold -> Buy$27.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014Piper JaffrayLower Price Target$28.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014Canaccord GenuityLower Price TargetBuy$27.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
4/30/2014Canaccord GenuityLower Price TargetBuy$28.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014Piper JaffrayBoost Price Target$26.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014Leerink SwannBoost Price Target$26.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014WallachBeth CapitalDowngradeBuy -> Hold$23.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
1/22/2014Canaccord GenuityBoost Price TargetBuy$26.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
10/31/2013Piper JaffrayBoost Price TargetOverweight$22.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
10/31/2013Canaccord GenuityBoost Price TargetBuy$24.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
10/14/2013Goldman SachsDowngradeBuy -> Neutral$19.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2013Canaccord GenuityBoost Price TargetBuy$22.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
6/24/2013OppenheimerBoost Price TargetOutperform$18.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
6/17/2013Piper JaffrayReiterated RatingOverweightViewTweet This Rating  Share This Rating on StockTwits
6/17/2013Canaccord GenuityReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/17/2013WallachBeth CapitalInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
2/28/2013Piper JaffrayBoost Price Target$21.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Leerink SwannReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
12/14/2012Canaccord GenuityBoost Price TargetBuy$20.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/22/2012 forward)